Zannoni, Gian Franco
 Distribuzione geografica
Continente #
NA - Nord America 12.144
AS - Asia 10.041
EU - Europa 8.588
SA - Sud America 2.132
AF - Africa 358
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 16
Totale 33.301
Nazione #
US - Stati Uniti d'America 11.792
SG - Singapore 4.646
CN - Cina 2.086
DE - Germania 2.032
BR - Brasile 1.738
IT - Italia 1.636
SE - Svezia 1.521
VN - Vietnam 1.002
FR - Francia 782
UA - Ucraina 515
IN - India 489
IE - Irlanda 457
GB - Regno Unito 407
ID - Indonesia 309
FI - Finlandia 302
HK - Hong Kong 275
BD - Bangladesh 260
PL - Polonia 249
JP - Giappone 232
RU - Federazione Russa 207
TR - Turchia 166
CA - Canada 163
AR - Argentina 146
CI - Costa d'Avorio 141
NL - Olanda 127
IQ - Iraq 112
MX - Messico 112
EC - Ecuador 75
ZA - Sudafrica 71
AT - Austria 64
KR - Corea 57
BE - Belgio 52
PK - Pakistan 52
CO - Colombia 48
ES - Italia 45
SA - Arabia Saudita 40
IR - Iran 36
MA - Marocco 36
VE - Venezuela 34
UZ - Uzbekistan 31
CL - Cile 29
PH - Filippine 28
EG - Egitto 27
KE - Kenya 27
LT - Lituania 26
RO - Romania 26
JO - Giordania 23
PY - Paraguay 22
CZ - Repubblica Ceca 21
IL - Israele 21
AZ - Azerbaigian 20
CH - Svizzera 20
MY - Malesia 16
OM - Oman 16
UY - Uruguay 16
AE - Emirati Arabi Uniti 15
AU - Australia 15
JM - Giamaica 15
NP - Nepal 14
PE - Perù 14
KZ - Kazakistan 12
TN - Tunisia 12
HN - Honduras 11
LB - Libano 11
AL - Albania 9
BO - Bolivia 9
DO - Repubblica Dominicana 9
MD - Moldavia 9
RS - Serbia 9
BG - Bulgaria 8
BH - Bahrain 8
LV - Lettonia 8
PS - Palestinian Territory 8
PT - Portogallo 8
TT - Trinidad e Tobago 8
TW - Taiwan 8
DZ - Algeria 7
ET - Etiopia 7
HU - Ungheria 7
KG - Kirghizistan 7
PA - Panama 7
SY - Repubblica araba siriana 7
EU - Europa 6
GR - Grecia 6
NZ - Nuova Zelanda 6
SN - Senegal 6
AO - Angola 5
BY - Bielorussia 5
CR - Costa Rica 5
DK - Danimarca 5
GT - Guatemala 5
NO - Norvegia 5
XK - ???statistics.table.value.countryCode.XK??? 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BA - Bosnia-Erzegovina 4
BB - Barbados 4
MM - Myanmar 4
TH - Thailandia 4
CY - Cipro 3
GA - Gabon 3
Totale 33.230
Città #
Singapore 2.531
Chandler 1.760
San Jose 1.228
Ashburn 1.187
Beijing 467
Dublin 451
New York 385
Jacksonville 360
Rome 354
Los Angeles 341
Ho Chi Minh City 322
San Mateo 299
Dallas 284
Jakarta 270
Lauterbourg 258
Hanoi 247
Hong Kong 242
Tokyo 209
Milan 206
Boston 202
Warsaw 201
Wilmington 200
Hefei 194
Nanjing 194
Ann Arbor 189
Frankfurt am Main 177
Hyderabad 175
Dearborn 158
The Dalles 154
São Paulo 152
Munich 147
Princeton 147
Abidjan 141
Helsinki 122
Houston 120
Buffalo 114
Marseille 106
Moscow 106
Council Bluffs 102
Fairfield 99
Cattolica 97
Seattle 97
Izmir 96
Woodbridge 94
Santa Clara 92
Lawrence 79
Chicago 78
Nürnberg 76
Redwood City 74
Nanchang 68
Boardman 59
Rio de Janeiro 58
Brooklyn 56
Da Nang 56
Bremen 55
Paris 53
London 52
Atlanta 51
Seoul 51
Brussels 48
Hangzhou 48
Baghdad 47
Orem 47
Toronto 46
Denver 45
Zhengzhou 45
Redmond 44
Turku 44
Norwalk 43
Brasília 42
Haiphong 42
Kent 39
Lappeenranta 39
Tianjin 39
Lancaster 37
Chennai 36
Mexico City 36
Düsseldorf 35
St Louis 35
Stockholm 35
Johannesburg 34
Montreal 34
Nuremberg 34
Vienna 34
Belo Horizonte 33
Hebei 33
Jiaxing 33
Shanghai 33
Cambridge 32
Changsha 32
Phoenix 32
Amsterdam 31
Curitiba 31
Augusta 30
Shenyang 30
Dhaka 29
Falkenstein 29
Kunming 29
Mountain View 29
Quito 29
Totale 17.446
Nome #
Chromosome 9p deletion syndrome and sex reversal: novel findings and redefinition of the critically deleted regions 448
Prognostic role of topoisomerase-IIalpha in advanced ovarian cancer patients 310
BRAF (V600E) mutation analysis on liquid-based cytology-processed aspiration biopsies predicts bilaterality and lymph node involvement in papillary thyroid microcarcinoma 305
Transvaginal ultrasonography and magnetic resonance imaging for assessment of presence, size and extent of invasive cervical cancer. 223
Imaging in gynecological disease (15): clinical and ultrasound characteristics of uterine sarcoma 221
Human papillomavirus (HPV) infection in squamous cell carcinomas arising from the oropharynx: detection of HPV DNA and p16 immunohistochemistry as diagnostic and prognostic indicators--a pilot study 216
Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data 213
Aberrant non-canonical WNT pathway as key-driver of high-grade serous ovarian cancer development 213
Cervical cancer response to neoadjuvant chemoradiotherapy: MRI assessment compared with surgery. 205
Chromosome 9p deletion syndrome and sex reversal: novel findings and redefinition of the critically deleted regions. 194
Can radicality of surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment? 190
Application of liquid-based cytology to fine-needle aspiration biopsies of the thyroid gland 188
Effects of epidermal growth factor receptor blockade on ependymoma stem cells in vitro and in orthotopic mouse models 188
How to improve MRI accuracy in detecting deep infiltrating colorectal endometriosis: MRI findings vs. laparoscopy and histopathology. 188
N-Acetylcysteine and High-Dose Atorvastatin Reduce Oxidative Stress in an Ischemia-Reperfusion Model in the Rat Kidney 188
Is frozen section analysis of pelvic lymph nodes accurate in locally advanced cervical cancer patients administered preoperative chemoradiation? 177
Italian consensus conference on management of uterine sarcomas on behalf of S.I.G.O. (Societa' italiana di Ginecologia E Ostetricia) 174
Impact of COVID-19 in gynecologic oncology: a Nationwide Italian Survey of the SIGO and MITO groups 173
MRI anatomy of parametrial extension to better identify local pathways of disease spread in cervical cancer 171
A case of isolated ovarian recurrence from vulvar carcinoma. 170
Helicobacter pylori infection affects eosinophilic cationic protein in the gastric juice of patients with idiopathic chronic urticaria 169
Can radicality of surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment? 167
Clinical performance of human papillomavirus E6 and E7 mRNA testing for high-grade lesions of the cervix. 165
How to improve MRI accuracy in detecting deep infiltrating colorectal endometriosis: MRI findings vs. laparoscopy and histopathology 165
Semiquantitative evaluation of lymph-vascular space invasion in patients affected by endometrial cancer: Prognostic and clinical implications 165
Mesonephric-like adenocarcinoma of the endometrium: detailed molecular characterization of the first case showing a morphological continuum from mesonephric-like metaplasia and atypical mesonephric-like hyperplasia to adenocarcinoma 164
Dual Inhibitor AEE788 Reduces Tumor Growth in Preclinical Models of Medulloblastoma 163
MRI anatomy of parametrial extension to better identify local pathways of disease spread in cervical cancer. 162
Fusion imaging in the preoperative assessment of the extension of disease in patients with advanced ovarian cancer: feasibility and agreement with laparoscopic findings 162
[Laparoscopic diagnosis of peritoneal endometriosis] 161
High-risk HPV-positive and -negative high-grade cervical dysplasia: Analysis of 5-year outcomes 160
Should a renal biopsy be performed at the first relapse of 'clinical nephrotic syndrome'? 156
Placental and infant metastasis of maternal melanoma: a new case. 156
RNA (E6/E7) versus DNA (E6/E7) assays for risk evaluation in women infected with Human Papillomavirus (HPV) 155
HPV infection in squamous cell carcinomas arising from different mucosal sites of the head and neck region. Is p16 immunohistochemistry a reliable surrogate marker? 155
Secondary malignancies of the uterine cervix: a potential diagnostic pitfall 155
Identification of high-grade serous ovarian cancer miRNA species associated with survival and drug response in patients receiving neoadjuvant chemotherapy: a retrospective longitudinal analysis using matched tumor biopsie 155
Antitumor effect in medulloblastoma cells by gefitinib: Ectopic HER2 overexpression enhances gefitinib effects in vivo 153
Changes in the expression of oestrogen receptors and E-cadherin as molecular markers of progression from normal epithelium to invasive cancer in elderly patients with vulvar squamous cell carcinoma 152
Fetal Doppler velocimetry and bronchopulmonary dysplasia risk among growth-restricted preterm infants: An observational study 152
Follicular loss in endoscopic surgery for ovarian endometriosis: quantitative and qualitative observations 152
BRAF (V600E) mutation analysis on liquid-based cytology-processed aspiration biopsies predicts bilaterality and lymph node involvement in papillary thyroid microcarcinoma. 151
Prognostic role of the recepteur d'origine nantais (RON) expression in ovarian cancer patients 150
Increased expression of CD133 and reduced dystroglycan expression are strong predictors of poor outcome in colon cancer patients 150
Early-stage cervical cancer: tumor delineation by magnetic resonance imaging and ultrasound - a European multicenter trial 150
BRAF (V600E) mutation analysis on liquid-based cytology-processed aspiration biopsies predicts bilaterality and lymph node involvement in papillary thyroid microcarcinoma. 149
Simultaneous ovarian and endometrial osseous metaplasia: a case report 149
PRospective Imaging of CErvical cancer and neoadjuvant treatment (PRICE) study: role of ultrasound to predict partial response in locally advanced cervical cancer patients undergoing chemoradiation and radical surgery 149
Management of adnexal masses with unexpected intracystic vegetation detected during laparoscopy. 147
The role of 18F-FDG-PET/CT in predicting the histopathological response in locally advanced cervical carcinoma treated by chemo-radiotherapy followed by radical surgery: a prospective study 147
Gender influences the class III and V β-tubulin ability to predict poor outcome in colorectal cancer 146
Mutational status of KRAS, NRAS, and BRAF in primary clear cell ovarian carcinoma 145
Imaging in gynecological disease (13): clinical and ultrasound characteristics of endometrioid ovarian cancer 145
Deep-Learning to Predict BRCA Mutation and Survival from Digital H&E Slides of Epithelial Ovarian Cancer 144
Imaging in gynecological disease (12): clinical and ultrasound features of invasive and non-invasive malignant serous ovarian tumors 143
Back to the future: The impact of oestrogen receptor profile in the era of molecular endometrial cancer classification 142
A) Steatohepatitis during methylprednisolone therapy for ulcerative colitis exacerbation 142
Helicobacter pylori CagA-positive strains affect oxygen free radicals generation by gastric mucosa 141
Placental and infant metastasis of maternal melanoma: A new case. 141
The vulvar immunohistochemical panel (Vip) project: Molecular profiles of vulvar squamous cell carcinoma 141
Histopathological evaluation of tumor-infiltrating lymphocytes (TILs) as predictive biomarker for hormone receptors status, proliferative activity and clinical outcome in her-2 positive breast cancer 141
Aymptomatic intrathyroidal parathyroid adenoma: case report and differential diagnosis with thyroid neoplasms 140
Imaging in gynecological disease (14): clinical and ultrasound characteristics of ovarian clear cell carcinoma 140
Uterine tumor resembling ovarian sex-cord tumor: Conservative surgery with successful delivery and case series 140
Infiltrating T lymphocytes and programmed cell death protein-1/programmed death-ligand 1 expression in endometriosis-associated ovarian cancer 140
Human papillomavirus independent status on pathologic response and outcomes in locally advanced cervical cancer managed with chemoradiotherapy followed by surgery 139
Placental and infant metastasis of maternal melanoma: A new case. 139
Multiple direct and indirect mechanisms drive estrogen-induced tumor growth in high grade serous ovarian cancers 139
Cytoplasmic expression of oestrogen receptor beta (ERβ) as a prognostic factor in vulvar squamous cell carcinoma in elderly women. 139
Current Prognostic and Predictive Biomarkers for Endometrial Cancer in Clinical Practice: Recommendations/Proposal from the Italian Study Group 139
Thyroid fine-needle aspiration cytology processed by ThinPrep: an additional slide decreased the number of inadequate results 137
Diagnostic efficacy of conventional as compared to liquid-based cytology in thyroid lesions. Evaluation of 10,360 fine needle aspiration cytology cases 137
Minimally Invasive Approach in Type II Endometrial Cancer: Is It Wise and Safe? 135
Prognostic factors value of germline and somatic brca in patients undergoing surgery for recurrent ovarian cancer with liver metastases 135
Outcomes of High-Grade Cervical Dysplasia with Positive Margins and HPV Persistence after Cervical Conization 134
Sonographic features of primary ovarian fibrosarcoma: a report of two cases. 133
Sexual dimorphism in medulloblastoma features 133
Pathologic response to neoadjuvant chemotherapy in advanced ovarian cancer: utility of a scoring system to predict outcomes 133
Imaging in gynecological disease (11): clinical and ultrasound features of mucinous ovarian tumors 133
The emerging and challenging role of PD-L1 in patients with gynecological cancers: An updating review with clinico-pathological considerations 132
Possible involvement of hMLH1, p16(INK4a) and PTEN in the malignant transformation of endometriosis 132
Does high-grade endometrioid carcinoma (grade 3 FIGO) belong to type I or type II endometrial cancer? A clinical-pathological and immunohistochemical study 132
The multiple facets of ovarian high grade serous carcinoma: A review on morphological, immunohistochemical and molecular features 131
Morphology and immunophenotyping of a monolateral ovotestis in a 46,XderY/45,X mosaic individual with ambiguous genitalia 131
Contrast-enhanced ultrasonography in chronic glomerulonephritides: correlation with histological parameters of disease activity 131
Validation of tumour-free distance as novel prognostic marker in early-stage cervical cancer: a retrospective, single-centre, cohort study 131
FOXL2 molecular status in adult granulosa cell tumors of the ovary: A study of primary and metastatic cases 130
Hepatoceliac Lymph Node Involvement in Advanced Ovarian Cancer Patients: Prognostic Role and Clinical Considerations 130
Serous ovarian carcinoma recurring as a heterologous carcinosarcoma 129
Antitumor effect in medulloblastoma cells by gefitinib: Ectopic HER2 overexpression enhances gefitinib effects in vivo. 129
Follicular loss in endoscopic surgery for ovarian endometriosis: quantitative and qualitative observations 129
The role of liquid based cytology and ancillary techniques in the peritoneal washing analysis: Our institutional experience 129
Clinicopathological analysis of mixed endometrial carcinomas: clinical relevance of different neoplastic components 129
Preoperative Anti-Class III β-Tubulin Antibodies As Relevant Clinical Biomarkers in Ovarian Cancer 129
Mismatch repair-deficiency specifically predicts recurrence of atypical endometrial hyperplasia and early endometrial carcinoma after conservative treatment: A multi-center study 128
Mismatch Repair Deficiency as a Predictive and Prognostic Biomarker in Endometrial Cancer: A Review on Immunohistochemistry Staining Patterns and Clinical Implications 127
Sentinel-node biopsy in apparent early stage ovarian cancer: final results of a prospective multicentre study (SELLY) 126
Prognostic role of metastasis tumor antigen 1 in patients with ovarian cancer: a clinical study 126
Salvage lymphadenectomy in recurrent ovarian cancer patients: Analysis of clinical outcome and BRCA1/2 gene mutational status 126
Diagnostic performance of preoperative [18F]FDG-PET/CT for lymph node staging in vulvar cancer: a large single-centre study 126
Totale 15.790
Categoria #
all - tutte 142.557
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 142.557


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202143 0 0 0 0 0 0 0 0 0 0 0 43
2021/20221.964 144 113 36 189 99 62 47 316 84 104 339 431
2022/20234.592 560 637 340 683 241 594 281 391 554 61 165 85
2023/20242.358 93 674 77 126 82 343 138 98 49 134 289 255
2024/20255.284 75 129 363 206 383 221 237 214 702 651 1.148 955
2025/202614.100 1.937 450 998 1.655 2.272 718 2.376 686 917 977 558 556
Totale 33.825